Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PZ HTL SA
GLOBETECH PUBLISHING LLC

Major European Research Project to Focus on Detection and Prevention of Rheumatoid Arthritis

By BiotechDaily International staff writers
Posted on 14 Aug 2013
The European Union has agreed to fund a multimillion euro research project aimed at detection and prevention of rheumatoid arthritis in individuals who do not yet have symptoms of the disease.

Funding for the first four years of the EuroTEAM (Towards Early diagnosis and biomarker validation in Arthritis Management) project will be more than 5.7 million euros. These funds will underwrite the research efforts of 13 academic partners from six European countries - the United Kingdom, the Netherlands, Sweden, Switzerland, Germany, and Austria, as well as three industry partners, from Germany, the Netherlands, and Iceland.

The biotech company ORGENTEC Diagnostika (Mainz, Germany), which will head up the search for biomarkers in the blood, will be a major player on EuroTEAM. ORGENTEC is a global leader in development, production, and marketing of test systems for laboratory diagnostics. The company offers numerous highly specific ELISA tests, immunoblots, and kits for immunofluorescence assays. Its point of care test "rheumachec" was the first rapid test for diagnosing rheumatoid arthritis.

In the case of a chronic inflammatory disease such as rheumatoid arthritis, the goal is prevention. Development of preventive strategies and therapies requires (1) identification of biomarkers that can be used to predict an individual's risk of developing the disease, and (2) identification and characterization of modifiable disease mechanisms that can be manipulated in the early phases of disease.

The key objective of the TEAM consortium is to specifically identify diagnostic biomarkers and disease mechanisms operating during the transition from health to rheumatoid arthritis. The plan is to achieve this by developing a collaborative, integrated program of work that will link academic researchers with key SMEs (small and medium sized enterprises) involved in biomarker development to produce a personalized predictive biomarker profile for patients destined to develop rheumatoid arthritis. Ultimately, the project will directly involve other medical specialists and patients.

Related Links:
ORGENTEC Diagnostika



comments powered by Disqus

Channels

Genomics/Proteomics

view channel

New Program Encourages Wide Distribution of Genomic Data

A new data sharing program allows genomics researchers and practitioners to analyze, visualize, and share raw sequence data for individual patients or across populations straight from a local browser. The sequencing revolution is providing the raw data required to identify the genetic variants underlying rare diseases... Read more

Drug Discovery

view channel
Image: The nano-cocoon drug delivery system is biocompatible, specifically targets cancer cells, can carry a large drug load, and releases the drugs very quickly once inside the cancer cell. Ligands on the surface of the \"cocoon\" trick cancer cells into consuming it. Enzymes (the “worms\" in this image) inside the cocoon are unleashed once inside the cell, destroying the cocoon and releasing anticancer drugs into the cell (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Novel Anticancer Drug Delivery System Utilizes DNA-Based Nanocapsules

A novel DNA-based drug delivery system minimizes damage to normal tissues by utilizing the acidic microenvironment inside cancer cells to trigger the directed release of the anticancer drug doxorubicin (DOX).... Read more

Lab Technologies

view channel

Experimental Physicists Find Clues into How Radiotherapy Kills Cancer Cells

A new discovery in experimental physics has implications for a better determination of the process in which radiotherapy destroys cancer cells. Dr. Jason Greenwood from Queen’s University Belfast (Ireland) Center for Plasma Physics collaborated with scientists from Italy and Spain on the work on electrons, and published... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.